Risk factors associated with atrial fibrillation in hypertrophic cardiomyopathy

被引:0
|
作者
Dalos, D. [1 ]
Dachs, T. [1 ]
Srdits, M. [1 ]
Stix, L. [1 ]
Kronberger, C. [1 ]
Rettl, R. [1 ]
Binder, C. [1 ]
Duca, F. [1 ]
Schrutka, L. [1 ]
Eslam, R. Badr [1 ]
Kastner, J. [1 ]
Bonderman, D. [2 ]
Gwechenberger, M. [1 ]
机构
[1] Med Univ Wien, Vienna, Austria
[2] Klin Favoriten, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
6.3
引用
收藏
页码:S90 / S91
页数:2
相关论文
共 50 条
  • [41] Polygenic risk score for prediction of atrial fibrillation according to presence of the hypertrophic cardiomyopathy
    Lee, Y.
    Yang, P.
    Jang, E.
    Kim, D.
    Yu, H. T.
    Kim, T. H.
    Uhm, J. S.
    Sung, J. H.
    Pak, H. N.
    Lee, M. H.
    Kim, J. B.
    Joung, B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [42] Stroke risk in hypertrophic cardiomyopathy patients with atrial fibrillation: a nationwide database study
    Hsu, Jung-Chi
    Huang, Ya-Ting
    Lin, Lian-Yu
    AGING-US, 2020, 12 (23): : 24219 - 24227
  • [43] Polygenic risk score for prediction of atrial fibrillation according to presence of the hypertrophic cardiomyopathy
    Lee, Y.
    Yang, P.
    Jang, E.
    Kim, D.
    Yu, H. T.
    Kim, T. H.
    Uhm, J. S.
    Sung, J. H.
    Pak, H. N.
    Lee, M. H.
    Kim, J. B.
    Joung, B.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [44] Epicardial Adipose Tissue Is Associated With Prevalent Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy
    Muhib, Sharifi
    Fujino, Takayuki
    Sato, Nobuyuki
    Hasebe, Naoyuki
    INTERNATIONAL HEART JOURNAL, 2013, 54 (05) : 297 - 303
  • [45] PERSISTENCE OF LEFT ATRIAL THROMBUS AND RISK OF INCIDENT THROMBOEMBOLISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND ATRIAL FIBRILLATION
    Julakanti, Raghav
    Burczak, Dan
    Balla, Abdalla Kara
    Scott, Christopher
    Geske, Jeffrey Benjamin
    Ommen, Steve R.
    Gersh, Bernard J.
    Nkomo, Vuyisile Tlhopane
    Noseworthy, Peter
    Siontis, Konstantinos
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 691 - 691
  • [46] Left atrial remodelling after septal myectomy is associated with a reduced 5-year risk of atrial fibrillation in hypertrophic cardiomyopathy
    Bataiosu, R.
    Scolari, F. L.
    Brahmbhatt, D.
    Hoss, S.
    Chow, C.
    Cooper, C.
    Tsoi, M.
    Rowin, E.
    Maron, M. S.
    Billia, F.
    Ralph-Edwards, A.
    Rakowski, H.
    Adler, A.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1726 - 1726
  • [47] Left atrial remodelling in hypertrophic cardiomyopathy, contributing factors and associated outcomes
    Cuddy, S.
    Kaynor, E.
    Nutakki, K.
    Cirino, A.
    Ho, C. Y.
    Lakdawala, N. K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 275 - 275
  • [48] Atrial Fibrillation Prevalence With Mavacamten for Obstructive Hypertrophic Cardiomyopathy
    Jaikumar, Likhitesh
    Biswas, Monodeep
    Kagan, Calvin
    Amara, Richard S.
    Reck, Kim M.
    Shorofsky, Stephen
    Dickfeld, Timm
    Wang, Libin
    See, Vincent Y.
    CIRCULATION, 2023, 148
  • [49] Catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy
    Prutkin, Jordan M.
    Owens, David S.
    HEART, 2016, 102 (19) : 1513 - 1514
  • [50] Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy
    Cochet, Hubert
    Morlon, Lucas
    Verge, Marie-Philippe
    Salel, Marjorie
    Camaioni, Claudia
    Reynaud, Amelie
    Peyrou, Jerome
    Ritter, Philippe
    Jais, Pierre
    Laurent, Francois
    Lafitte, Stephane
    Montaudon, Michel
    Reant, Patricia
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2018, 111 (10) : 591 - 600